ResearcherUniversity of PittsburghNo recent work listed
Samer T. Tohme
Matched on ORCID iD 0000-0001-8770-9706; OpenAlex author ID A5020247147. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 9
2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 3 papers
Papers 5
- Medicaid expansion and the management of pancreatic cancer. Last author DOI 10.1002/jso.26515↗
- Safety and oncologic efficacy of robotic compared to open pancreaticoduodenectomy after neoadjuvant chemotherapy for pancreatic cancer. First author DOI 10.1007/s00464-020-07638-w↗
- Impact of Resection Margin Status in Patients with Pancreatic Cancer: a National Cohort Study. Last author DOI 10.1007/s11605-020-04870-6↗
- Long-term oncologic outcomes of robotic and open pancreatectomy in a national cohort of pancreatic adenocarcinoma. Co-author DOI 10.1002/jso.25958↗
- Race and Health Disparities in Patient Refusal of Surgery for Early-Stage Pancreatic Cancer: An NCDB Cohort Study. Co-author DOI 10.1245/s10434-018-6680-6↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Amer H. Zureikat · 4 shared papers, 2020–2021 · strength 0.53
- Paper Safety and oncologic efficacy of robotic compared to open pancreaticoduodenectomy after neoadjuvant chemotherapy for pa… DOI 10.1007/s00464-020-07638-w↗
- Paper Impact of Resection Margin Status in Patients with Pancreatic Cancer: a National Cohort Study. DOI 10.1007/s11605-020-04870-6↗
- Paper Medicaid expansion and the management of pancreatic cancer. DOI 10.1002/jso.26515↗
- Ibrahim Nassour · 4 shared papers, 2020–2021 · strength 0.53
- Paper Safety and oncologic efficacy of robotic compared to open pancreaticoduodenectomy after neoadjuvant chemotherapy for pa… DOI 10.1007/s00464-020-07638-w↗
- Paper Impact of Resection Margin Status in Patients with Pancreatic Cancer: a National Cohort Study. DOI 10.1007/s11605-020-04870-6↗
- Paper Medicaid expansion and the management of pancreatic cancer. DOI 10.1002/jso.26515↗
- Richard S. Hoehn · 4 shared papers, 2020–2021 · strength 0.53
- Paper Safety and oncologic efficacy of robotic compared to open pancreaticoduodenectomy after neoadjuvant chemotherapy for pa… DOI 10.1007/s00464-020-07638-w↗
- Paper Impact of Resection Margin Status in Patients with Pancreatic Cancer: a National Cohort Study. DOI 10.1007/s11605-020-04870-6↗
- Paper Medicaid expansion and the management of pancreatic cancer. DOI 10.1002/jso.26515↗
- Alessandro Paniccia · 4 shared papers, 2020–2021 · strength 0.53
- Paper Safety and oncologic efficacy of robotic compared to open pancreaticoduodenectomy after neoadjuvant chemotherapy for pa… DOI 10.1007/s00464-020-07638-w↗
- Paper Impact of Resection Margin Status in Patients with Pancreatic Cancer: a National Cohort Study. DOI 10.1007/s11605-020-04870-6↗
- Paper Medicaid expansion and the management of pancreatic cancer. DOI 10.1002/jso.26515↗
- Christof Kaltenmeier · 3 shared papers, 2018–2021 · strength 0.37
- Paper Impact of Resection Margin Status in Patients with Pancreatic Cancer: a National Cohort Study. DOI 10.1007/s11605-020-04870-6↗
- Paper Medicaid expansion and the management of pancreatic cancer. DOI 10.1002/jso.26515↗
- Paper Race and Health Disparities in Patient Refusal of Surgery for Early-Stage Pancreatic Cancer: An NCDB Cohort Study. DOI 10.1245/s10434-018-6680-6↗
- Mohamed A. Adam · 2 shared papers, 2020–2021 · strength 0.27
- Paper Safety and oncologic efficacy of robotic compared to open pancreaticoduodenectomy after neoadjuvant chemotherapy for pa… DOI 10.1007/s00464-020-07638-w↗
- Paper Long-term oncologic outcomes of robotic and open pancreatectomy in a national cohort of pancreatic adenocarcinoma. DOI 10.1002/jso.25958↗
- Caroline J. Rieser · 1 shared paper, 2021 · strength 0.13
- David L. Bartlett · 1 shared paper, 2020 · strength 0.11
- Allan Tsung · 1 shared paper, 2018 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.